Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drug
On Thursday, the Senate health committee met with Heidi Overton, nominee for commissioner of the Food and Drug Administration. When asked about her views on mifepristone, a key abortion medication, Overton danced around the issue. As the CEO of…
ImpactMinor 12/100
Why it mattersRule-based estimate: event keywords (+6), soft/evergreen signals; trust 8/10.
RegionsGlobal
Published8 h ago (Fri, 25 Sep 2026 14:39:38 GMT)
RetrievedFri, 25 Sep 2026 18:00:29 GMT via rss
ClassifiedFri, 25 Sep 2026 18:00:59 GMT by heuristic
AuthorJulie F. Kay